/Investor DB

NuFund Venture Group — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Seal Rock Therapeuticssealrocktx.comJan 2022

Sealrock is a drug development company whose team has worked on the discovery, development, and commercialization of FDA-approved drugs.

BiotechHealthtechSeattle, US

Kathleen Elias(VP of Research & Translational Medicine / Co-Founder)Neil McDonnell(Chief Executive Officer / Co-Founder)Keith Wycoff(Director)Artur Plonowski(Chief Scientific Officer / Co-Founder)

Co-investorsElma Ventures

VerImmuneverimmune.comin𝕏Jul 2022 · $2.5M

VerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity.

BiotechHealthtechMedical DevicesBethesda, US

JOSHUA WANG(Executive Officer, Director, Promoter)inJOHN TROYER(Executive Officer)

BoardCYNTHIA POH(Director)KEVIN KOH RONGSHENG(Director)HAOLIN SUNG(Director)inCHE HSU(Director)in

Co-investorsGaingelsMana VenturesMaryland TEDCOSymbiotic VenturesUlu Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.